-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Kymera Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q3 2024.
- Kymera Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 76.1M shares, a 30.3% increase year-over-year.
- Kymera Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 58.4M shares, a 8.22% increase from 2022.
- Kymera Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 53.9M shares, a 12.4% increase from 2021.
- Kymera Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 48M shares, a 177% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)